These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma. D'Alonzo GE; Nathan RA; Henochowicz S; Morris RJ; Ratner P; Rennard SI JAMA; 1994 May; 271(18):1412-6. PubMed ID: 7909853 [TBL] [Abstract][Full Text] [Related]
3. Salmeterol xinafoate in asthma. Palmer JB; Oxford JM JAMA; 1994 Nov 23-30; 272(20):1575-6. PubMed ID: 7966861 [No Abstract] [Full Text] [Related]
4. Dose equivalence of drugs for asthma. Lötvall J; Svedmyr N BMJ; 1993 Apr; 306(6884):1066. PubMed ID: 8490515 [No Abstract] [Full Text] [Related]
5. Dose equivalence of drugs for asthma. Doull IJ; Patel SR BMJ; 1993 Apr; 306(6884):1066. PubMed ID: 8490514 [No Abstract] [Full Text] [Related]
6. Several studies have shown salmeterol to be more potent than salbutamol for systemic effects. Bennett J; Tattersfield AE BMJ; 1997 Jul; 315(7100):121. PubMed ID: 9240063 [No Abstract] [Full Text] [Related]
7. Long acting inhaled beta2-agonists: anti-inflammatory effects not evident during treatment of day to day asthma. Durham S Eur Respir J; 1999 Aug; 14(2):249-50. PubMed ID: 10515396 [No Abstract] [Full Text] [Related]
8. Bronchodilator reversibility to albuterol predicts bronchodilator response to salmeterol. Lipworth BJ; Jackson CM Chest; 2002 Apr; 121(4):1382. PubMed ID: 11948092 [No Abstract] [Full Text] [Related]
9. Bronchodilator treatment in asthma: continuous or on demand? Hilton CJ; Fuller RW BMJ; 1992 Jan; 304(6819):121. PubMed ID: 1346579 [No Abstract] [Full Text] [Related]
10. The expanding role of long-acting beta-agonists. Donohue JF Chest; 2000 Aug; 118(2):283-5. PubMed ID: 10936111 [No Abstract] [Full Text] [Related]
11. [More asthma death cases with beta-2-antagonists: with inhaled corticosteroids on the safe side?]. Wepner U MMW Fortschr Med; 2007 Dec; 149(49-50):20. PubMed ID: 18240436 [No Abstract] [Full Text] [Related]
12. [Efficacy of salmeterol in patients with allergic bronchial asthma]. Pacor ML; Biasi D; Cortina P; Maleknia T; Lunardi C Clin Ter; 1994 Aug; 145(8):131-4. PubMed ID: 7955958 [TBL] [Abstract][Full Text] [Related]
13. [Bronchial asthma -- to set the measuring rod higher. Combination therapy defines asthma control anew]. MMW Fortschr Med; 2003 Nov; 145(46):46-7. PubMed ID: 14699833 [No Abstract] [Full Text] [Related]
15. A comparison of the efficacy of long-acting beta 2-agonists: eformoterol via Turbohaler and salmeterol via pressurized metered dose inhaler or Accuhaler, in mild to moderate asthmatics. Force Research Group. Campbell LM; Anderson TJ; Parashchak MR; Burke CM; Watson SA; Turbitt ML Respir Med; 1999 Apr; 93(4):236-44. PubMed ID: 10464887 [TBL] [Abstract][Full Text] [Related]
16. Effect of addition of salmeterol versus doubling the dose of fluticasone propionate on specific airway resistance in children with asthma. Murray CS; Custovic A; Lowe LA; Aldington S; Williams M; Beasley R; Woodcock A Allergy Asthma Proc; 2010; 31(5):415-21. PubMed ID: 20929609 [TBL] [Abstract][Full Text] [Related]